PREPARATION AND EVALUATION OF PARA-[AT-211]ASTATOBENZOYL LABELED ANTIRENAL CELL-CARCINOMA ANTIBODY A6H F(AB')2 - IN-VIVO DISTRIBUTION COMPARISON WITH PARA-[I-125]IODOBENZOYL LABELED A6H F(AB')2
Ds. Wilbur et al., PREPARATION AND EVALUATION OF PARA-[AT-211]ASTATOBENZOYL LABELED ANTIRENAL CELL-CARCINOMA ANTIBODY A6H F(AB')2 - IN-VIVO DISTRIBUTION COMPARISON WITH PARA-[I-125]IODOBENZOYL LABELED A6H F(AB')2, Nuclear medicine and biology, 20(8), 1993, pp. 917-927
A preliminary investigation of an At-211 labeled anti-renal cell carci
noma antibody fragment, A6H F(ab')2, was conducted. In the investigati
on, A6H F(ab')2 was labeled by conjugation with N-succinimidyl p-[At-2
11]astatobenzoate, and the in vivo biodistribution was evaluated in at
hymic mice bearing TK-82 renal cell carcinoma xenografts. As a control
, p-[I-125]iodobenzoyl labeled A6H F(ab')2 was coinjected with the ast
atinated F(ab')2. The data obtained demonstrated that the two radiolab
els (At-211 and I-125) had quite similar distributions, providing evid
ence that the At-211 remained attached to the A6H F(ab')2 in vivo. Fur
ther, the astatinated antibody attained a 2:1 tumor-to-blood ratio, an
d greater than 35:1 tumor-to-muscle ratio, at 4 h post-injection, sugg
esting that this antibody conjugate could be used to evaluate treatmen
t of metastatic renal cell carcinoma in a mouse model.